Actual Conditions of the Mixing of Antineoplastic Drugs for Injection in Hospitals in Osaka Prefecture, Japan
スポンサーリンク
概要
- 論文の詳細を見る
We conducted a questionnaire survey in order to grasp the actual conditions under which antineoplastic drugs are mixed for injection in hospitals. Questionnaires were sent to all 155 hospitals with 100 or more beds for general patients in Osaka Prefecture, Japan. The response rate was 69.0%. Mixing of antineoplastic drugs was done in 81.3% of the hospitals. The questionnaire was answered by doctors in 17.2% of the hospitals with antineoplastic drugs, nurses in 11.5%, and pharmacists in 70.1%. Mixing of antineoplastic drugs was done by doctors in 58.6% of the hospitals, nurses in 44.8%, and pharmacists in 63.2% (multiple answers). Occupational exposure to antineoplastic drugs was recognized in 97.7% of the hospitals. The mean frequency of the mixing operation was 8.8 d per month per worker. The mean number of antineoplastic drugs handled was 7.4 types. Guidelines for the safe handling of antineoplastic drugs were used in 52.8% of the hospitals and a biological safety cabinet was available in 57.4%. Gloves, mask, gown and goggles were used in 82.7, 69.0, 62.1 and 36.8% of the hospitals, respectively, but no personal protective equipment was used in 10.1%. The safety precautions of the hospitals in which the number of beds was small tended to be fewer than those of the hospitals in which the number of beds was large. Used vials and ampoules were disposed of as clinical, infectious or exclusive antineoplastic drug waste by 74.7% of the hospitals. Safety measures for handling the excrement of patients treated with antineoplastic drugs were performed in 8.0% of the hospitals. In 43.7% of the hospitals, the responders had experienced accidents during antineoplastic drug preparation, such as drugs adhering to hands or eyes, drug leakage, accidental injection and cutting by ampoules. Because of the adverse effects of antineoplastic drugs, all hospitals in which the healthcare workers handle them should promote safety precautions.
- 社団法人日本産業衛生学会の論文
著者
-
Yoshida Jin
Department Of Environmental Health Osaka Prefectural Institute Of Public Health
-
KOSAKA Hiroshi
Department of Environmental Health, Osaka Prefectural Institute of Public Health
-
KUMAGAI Shinji
Department of Environmental Health, Osaka Prefectural Institute of Public Health
-
Nishida Shozo
Division Of Pharmacotherapy Kinki University School Of Pharmacy
-
Kosaka Hiroshi
Department Of Environmental Health Osaka Prefectural Institute Of Public Health
-
Kosaka Hiroshi
Department Of Applied Chemistry Faculty Of Science And Engineering Saga University
関連論文
- Genotoxic Risks to Nurses from Contamination of the Work Environment with Antineoplastic Drugs in Japan
- Platelet-Derived Growth Factor and its Receptors Are Expressed in Areas of Both Active Inflammation and Active Fibrosis in Inflammatory Bowel Disease
- Nitrogen-containing bisphosphonate, YM529/ONO-5920, inhibits macrophage inflammatory protein 1α expression and secretion in mouse myeloma cells
- B-19: Chaos of Yang-Mills Field in Class A Bianchi Spacetimes(Part II: Poster Contributions, The Next Chapter in Einstein's Legacy)
- Structural Effect of Phosphoric Esters Having Bulky Substituents on the Extraction of Rare Earth Elements
- Actual Conditions of the Mixing of Antineoplastic Drugs for Injection in Hospitals in Osaka Prefecture, Japan
- Sebaceous Carcinoma Arising in Nevus Sebaceus
- Quantitative determination of urinary metabolites of o-dichlorobenzene using a gas chromatograph
- Estimation of Dioxin Exposure Concentrations and Dioxin Intakes of Workers at Continuously Burning Municipal Waste Incinerators
- Relations between Exposure to 0-Dichlorobenzene and Concentrations of Urinary Metabolites
- A Case of Occupational Asthma Induced by Falcata Wood (Albizia falcataria)
- Health Effects of Acute Exposures to Methyl Bromide during Soil Fumigation Inside Greenhouses
- High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin
- Cyclosporin A inhibits late steps of T lymphocyte activation after transmembrane signaling.